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Abstract
BACKGROUND: The objective of this study was to semiquantitatively assess the degree of myocardial fluorodeoxyglucose 
(FDG) uptake in glucose-loaded myocardial viability positron emission tomography/computed tomography (PET/CT) scans, 
to calculate the myocardial to background index, and correlate the index with image quality assessed on the basis of visual 
qualitative assessment. 
MATERIAL AND METHODS: The myocardial FDG-PET/CT study was carried out in 69 non-diabetic patients, who had known 
coronary artery disease, by intravenous injection of 250 ± 70 MBq (range: 180–320 MBq) FDG. Images were interpreted visually 
and patients were divided into three groups according to the grade of myocardial uptake: optimal, suboptimal, and uninterpret-
able. Semiquantitative analysis was performed by calculating the standardized uptake value (SUVmax) for myocardium and 
background (blood pool) activity, and expressed as the myocardial to background (M/B) activity ratio.
RESULTS: On the basis of visual (qualitative) analysis, 60/69 (86.96%) patients showed optimal quality of FDG cardiac uptake, 
3/69 (4.35%) were suboptimal, and uninterpretable FDG PET scan results were found in 6/69 (8.70%) patients. The M/B index 
was found to be significantly higher in images of optimal vs. suboptimal quality (6.87 ± 3.99 vs. 1.65 ± 0.78 respectively; 
p < 0.0001). 
CONCLUSIONS: The index ratio of 2.2, which is consistent with the upper borderline value for visually uninterpretable images, 
was considered the cut-off value for scans of optimal and non-optimal quality.
KEY words: fluorodeoxyglucose-positron emission tomography, SUVmax, myocardial to background ratio, myocardial 
uptake, myocardial viability
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FDG-positron emission tomography (FDG-PET) cardiac imag-
ing is one of the most clinically applicable and sensitive proce-
dures for myocardial viability assessment. However, normal myocar-
dial metabolism is diverse which often results in heterogeneous ac-
cumulation of radiopharmaceutical. If the background activity is too 
high, the activity of the blood inside the left ventricle increase the 
number of counts due to the limitations of reconstruction algorithms. 
Since the myocardial images are always displayed normalized to the 
pixel of highest activity and the scale of visual presentation is linear, 
the images of not optimal quality might overestimate the viability 
and underestimate the scar. Moreover, there is lack of standardized 
software for cardiac PET imaging processing on most PET imaging 
systems. The viability assessment can be performed qualitatively 
and quantitatively with the use of the software designed originally 
for SPECT perfusion studies. Using quantitative analysis, area of 
reduced FDG uptake is reported as a percentage of the left ventricle, 
similar to the SPECT perfusion defects, where 50% threshold for 
viability assessment is commonly used [1, 2]. Automatic recognition 
of the left ventricular borders using only PET slices in cases where 
cardiac 18F-FDG uptake is scarce or heterogeneous is especially 
difficult. In our clinical experience many myocardial scans with high 
background activity are not conclusive and the repeat acquisition 
is essential. Owing to the dynamic progress of hybrid imaging most 
PET systems are in fact PET/CT. The standard evaluation of cardiac 
PET/CT imaging includes always a quick check-up of the quality of 
the fused images performed with the general software and then the 
use of specific cardiac programs for further semiquantitative and 
qualitative PET analysis, which is conclusive only when the image 
is of good quality. It will therefore be desirable to find an easy test 
allowing to check the image quality to ensure the conclusive result 
of further semiquantitative assessment. FDG accumulation can be 
easily calculated with the use of regions of interest precisely placed 
with the help of CT morphologic data. More importantly, the use of 
PET/CT allows for the quantitative assessment with the use of the 
FDG standard uptake value (SUV). 
The aim of this study was to obtain myocardial to background 
(blood pool) (M/B) SUVmax ratio in order to assess the cut-off 
value optimal for further application of cardiac specific software 




Cardiac FDG-PET/CT was performed for clinical purposes in 
a group of 69 non-diabetic patients with coronary artery disease 
confirmed using coronary angiography and fasting blood glucose 
below 120 mg/dL. The subjects included 56 men and 13 women 
with a mean age of 62 ± 11.1 years. 
Imaging protocol
If informed consent was waived by the institutional review board 
(IRB) for a study, an intravenous glucose load protocol was applied 
to all the patients in accordance with a previously published de-
scription [3]. Each patient received an intravenous glucose-insulin 
injection after overnight fasting, which was well tolerated.
The injected activity was 250 ± 70 MBq (range, 180–320 MBq). 
The mean time from FDG administration to image acquisition 
was 58 min (range, 35–100 min; standard deviation [SD] = 19.2). 
Acquisition parameters
Images were acquired with a Biograph 64 PET/CT scanner (Sie-
mens Medical Solutions, Inc.) operating with Somaris/5 SyngoCT 
2006 software, as described previously [4]. 
Technical parameters of PET and CT scans are listed below:
 — For topogram: scan length 256 mm, slice 0,6 mm, scan time 
0,2 s, mA 35; kV 120, tube position: top , position craniocaudal.
 — For CT scan: Scan time 3,36 s, slice 3 mm, delay 4 s, no of 
images 111, Eff mAs-11, kV 120, FoV 700 mm, recon type axial. 
 — For PET scan: scan range match CT FoV, no of beds: 1, scan 
duration /bed 10 min, scan direction: craniocaudal. A pixel size 
was 2.57 × 2.57 × 2.46 mm, a 128 × 128 matrix, and 2 mm 
slice thickness, zoom 2 was used. 
CT data were used both for attenuation correction of PET 
data and anatomic structure recognition for precise localization 
of 18F-FDG uptake. 
Image reconstruction parameters
Acquired PET data were reconstructed qualitatively with the use 
of Syngo MI application software. Random and scatter correction 
was used as implemented by the manufacturer.
PET data reconstruction: a filtered backprojection method with 
10 mm Gaussian filter was used. 
CT reconstruction parameters: recon type was axial, kernel 
B18f very smooth, window: abdomen
The semiquantitative PET/CT analysis was performed using the 
Syngo TrueD software package. Processed PET/CT images were 
corrected for attenuation and reconstructed, then displayed in 
coronal, transverse, and sagittal planes. 
Statistical analysis
The statistical analysis was performed using Statistica software 
and the non-parametric Mann-Whitney U test.
Image analysis
A qualitative PET and semiquantitative PET/CT assessments of 
the acquired data were performed in all patients. Semiquantita-
tive and visual image analysis was performed by 2 independent 
investigators. 
Qualitative PET data assessment
A visual analysis of acquired PET images was performed using 
the Syngo Software: TrueX and MI Syngo applications. The qua- 
lity of the scans has been assessed visually by two independent 
observers. In the event of discordant findings, the final decision 
was made by consensus. 
Visual analysis was based on a 3-point scale:
 — An image was assessed as optimal if the myocardial FDG 
concentration was high, distribution was homogenous and 
background activity was visually low. The myocardial activity 
clearly exceeded the liver.
 — An image was classified as suboptimal when the background 
activity was visually moderate, and/or the FDG myocardial dis-
tribution was inhomogeneous, accumulation comparable with 
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the liver but there were no technical problems with automatic 
endocardial and epicardial borders recognition in the QPS 
application software. 
 — An image was classified as uninterpretable if it is inadequate 
for assessing visually myocardial FDG uptake and had high 
background activity is present.
For statistical analysis, patients were divided into two sub-
groups: Group 1 — a group with optimal image quality and group 
2 — a group including suboptimal and uninterpretable results.
Semiqualitative PET data assessment
A semiquantitative PET analysis was performed with the use 
of QPS (Cedars-Sinai Medical Center), a software package that 
offers a semiquantitative analysis, with automatic endocardial and 
epicardial borders recognition. A 17-segment polar map was used. 
A 50% threshold for viability assessment was used [1, 2].
Semiquantitative analysis of PET/CT image
Regions of interest (ROIs) were drawn on the transversal 
fused PET/CT images, and SUVmax was calculated. For the de-
termination of cardiac FDG accumulation, the three-dimensional 
ROI was placed over the heart muscle to measure the SUVmax 
of the myocardium (SUVmaxMyo). For the determination of the 
background blood activity, an ROI of 0.5–1.0 cm2 was placed in 
an area of the left ventricle, near the mitral valve. A two-dimensional 
ROI was chosen for the background calculation to avoid false 
results caused by high activity from the surrounding left ventricu-
lar muscle. Furthermore, owing to the above mentioned high left 
ventricular muscle activity possibly causing partial volume effect, 
the background activity was compared in two areas: Inside the left 
ventricle and in the descending aorta (SUVmax LV and SUVmax 
Ao, respectively). The image quality was expressed as the M/B 
activity ratio. 
Ethical considerations
The knowledge about the specific cut off value will stress the 
problem of risk of inadequate viability assessment in case of hete- 
rogeneous, low FDG myocardial accumulation. Even if our calcu-
lation will be specific for particular reconstruction and acquisition 
parameters the knowledge will optimize and justify the necessity for 
repeated acquisition, which (if necessary) will be performed on the 
same day without additional tracer injection. Subjects have received 
a full disclosure of the nature of the study, the risks, benefits and 
alternatives, with an extended opportunity to ask questions. All data 
collected would be coded to protect identity and privacy.
The project has educational and scientific value. It is not in-
volving the additional risk, only such, as is present during average 
standard PET/CT scan. The potential risk to the participant is justi-
fied by the benefit of the knowledge gained, because thanks to 
this calculation there will be no need for additional repeated future 
FDG injection due to not conclusive results.
The proposed study is ethical in terms, and respecting the 
participants’ welfare and dignity and their right to privacy and 
confidentiality. 
Results
There were no statistically significant differences in the 
background glucose uptake between group 1 and group 2 
(98.85 ± 15.00 vs. 96.0 ± 10.54; p = 0.24, respectively, at the begin-
ning of FDG loading, 118.35 ± 20.3 vs. 127.11 ± 20.38; p = 0.81 
at the time of FDG injection). Additionally, there was no significant 
difference in time to FDG injection (60.9 ± 7.6 vs. 60.0 ± 10.5; 
p = 0.12, respectively). 
Qualitative assessment of the image quality
On the basis of visual (qualitative) analysis, 60/69 (86.96%) 
patients showed optimal quality FDG cardiac uptake (Fig. 1), 3/69 
(4.35%) were suboptimal (Fig. 2), and uninterpretable results were 
found in 6/69 (8.7%) patients (Fig. 3).
Semiquantitative PET/CT analysis
An analysis was performed on the basis of fused images in all 
69 patients. The available CT images allowed for the assessment 
of regional FDG accumulation even in patients with low myocardial 
uptake. Calculations were performed for the whole group and for 
Figure 1. Myocardial viability evaluated by 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) 
study in patients with optimal myocardial FDG uptake. A. A patient with previous myocardial infarction and no FDG uptake (no viability) in the apical 
region, myocardial to background (M/B) activity ratio (M/B index) = 7.0; B. A homogenous FDG uptake consistent with preserved left ventricular 
viability, M/B index = 4.34. SUVmaxMyo measurements in the presented scans show high SUVmaxMyo and low SUVmax LV 18 F-FDG activity
A B
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each subgroup of patients: Group 1 (optimal images) and group 2 
(suboptimal and uninterpretable images). The M/B uptake index 
was compared between groups and the p-value was calculated. 
Table 1 shows the SUVmax values of myocardial FDG uptake, 
background-blood pool uptake, and M/B calculated for each 
group of patients. 
The background activity for the left ventricle and aorta were 
compared. There was no statistically significant difference between 
SUVmax in the aorta and left ventricle: 1.57 ± 0.69 vs. 1.69 ± 0.77; 
p = 0.18 (Table 1).
The Mann-Whitney U test showed a statistically significant 
difference in the mean values of M/B index comparison between 
group 1 and group 2 (Table 2).
The mean M/B index value for group 1 was 6.87 compared 
with 1.65 for group 2. The mean M/B index value was 2.23 for the 
images of suboptimal quality and 1.36 for images of uninterpretable 
quality. The highest M/B index value for the uninterpretable im-
ages was 2.2. The lowest M/B index value for the images of optimal 
image quality was 2.5. The index ratio of 2.2, which is consistent 
with the upper borderline value for visually uninterpretable images, 
was considered the cut-off value for differentiating between scans of 
optimal and non-optimal quality.
Discussion
Hybrid imaging in nuclear cardiology
Dynamic progress in medical imaging has allowed the analy-
sis of an increasing number of parameters which may be important 
in understanding the mechanisms of the analyzed disease. An 
integrated PET/CT, where the functional scans are combined with 
CT is applied for many clinical purposes, including FDG myocardial 
viability assessment [5]. The possibility of the simultaneous analy-
sis of perfusion or metabolism and morphological recognition 
of myocardial structures, such as coronary arteries, calcified 
plaques [6], myocardial tumors [7, 8], or epicardial adipose tissue 
[9, 10], allows for a more complete diagnosis. Additionally, the use 
of PET/CT allows for easy and accurate attenuation correction and 
semiquantitative calculation of glucose accumulation. 
Evaluation of cardiac PET/CT image
The standard evaluation of cardiac PET/CT imaging includes al-
ways a quick check-up of the quality of the fused image performed 
with the general software and then the use of specific cardiac 
programs for further semiquantitative and qualitative evaluation. 
The quick assessment of general image quality is very important 
Figure 2. Myocardial viability 18F-FDG PET-CT study with suboptimal myocardial FDG uptake. Preserved heterogeneous FDG uptake pattern with 
high myocardial SUVmax uptake. A. M/B index = 2.67; B. M/B index = 2.18
A B
Figure 3. Myocardial viability 18F-FDG PET-CT study with uninterpretable myocardial FDG uptake. Absent FDG uptake, low myocardial SUVmax 
with high LV 18F-FDG blood pool activity. A. M/B index = 0.6; B. M/B index = 0.81
A B
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because the study can be repeated without additional FDG injection, 
if the image is not optimal. This first quality control of the PET/CT 
image is often performed by technician performing the scan, where 
easy indication: “if H/B ratio is below 2.2 — repeat the scan” is clear. 
Further analysis express the extent and severity of metabolic defect 
semiquantitatively in segmental polar map as the % of maximal pixel 
value. A 50% threshold for viability assessment is commonly used 
[1, 2]. If the background activity is to high, the activity of the blood 
inside left ventricle increase the number of counts due to limita-
tions of reconstruction algorithms. Since the semiquantitative image 
is always normalized to the pixel with highest activity and the scale 
of visual presentation is linear, the images of not optimal quality 
are overestimating the viability and underestimating the scar. In our 
clinical experience many myocardial scans with high background 
activity are not conclusive and the repeat evaluation is essential.
Quantitated myocardial FDG uptake as a monitoring 
tool for viability
The final PET image quality depends mostly on the myocardial 
and background FDG activity. There are only a few articles regarding 
the quantitative or semiquantitative assessment of image quality. 
Coulden et al. [11] suggested an SUVmax of 3.6 as the borderline 
for suppressed myocardium. In our group of patients, the mean 
value of the myocardial SUVmax in the group with uninterpretable 
image reached 2.82, and the highest individual value was 4.4. De-
spite the statistically significant difference between the myocardial 
SUVmax in both groups, the values were overlapping, as there 
were patients showing myocardial activity ranging approximately 
3–6 in all the analyzed groups. Our results suggest that the relation 
between the myocardium and background (i.e., the M/B index) may 
be a better indicator than the absolute SUVmax value for image 
quality and reliability of image interpretation. The M/B index was pre-
viously analyzed by Bax et al. [12], who compared three preparation 
protocols for patients: Oral glucose load, hyperinsulinemic clamp, 
and nicotinic acid derivative. Image quality was expressed as the 
M/B activity ratio. A ratio of 2.8–2.9 (± 0.7–0.8) was considered 
optimal. We recorded similar results in our group of patients; optimal 
FDG myocardial uptake observed was 2.5. The mean value of the 
M/B ratio in our group of patients was 6.87 (range, 2.5–21.2; SD, 
3.99). Although the patients with high myocardial FDG uptake were 
found in both analyzed groups, (mean values: 9.6 for optimal im-
ages and 3.61 for suboptimal and uninterpretable), the patients with 
suboptimal and uninterpretable image quality expressed higher 
background FDG activity that resulted in a significantly lower M/B 
index. High background (blood pool) activity reduces the image 
contrast, which reduces the diagnostic quality of the images. 
Importance of acquisition protocol modifications  
for FDG PET/CT imaging
An increased blood pool activity is probably a sign of delayed 
clearance of the radiotracer from blood or insufficient time for 
clearance of the tracer. Machac et al. [13] suggested repeated 
imaging after 30–60 min may improve the myocardium-to-blood 
pool contrast. In our group of patients, double time acquisition 
was performed in two cases of uninterpretable scans. In these 
cases there was no significant improvement in image quality. 
The double time acquisition was in turn helpful in patient with 
“not optimal” image quality, where better contrast was achieved 
in delayed acquisition. Owing to lower density counts caused by 
radioactivity decay following delayed acquisition and requirement 
Table 1. SUVmax values of myocardial FDG uptake, background-blood pool uptake, and myocardial to background index (M/B) for optimal, 
suboptimal, and uninterpretable visualization scans
SUVmax 
Mean ± SD  
(range)
All                   Group 1                                          Group 2






Myocardial 8.82 ± 4.32 
(1.3–19.7)
9.6 ± 4.06 
(1.3–19.7)
5.2 ± 0.79 
(4.6–6.1)
2.82 ± 1.11 
(1.4–4.4)
Left ventricle 1.69 ± 0.77  
(0.3–4.1)
1.57 ± 0.66 
(0.3–3.1)
2.6 ± 1.10 
(1.5–3.7)
2.42 ± 0.98 
(1.3–4.1)
Table 2. SUVmax values of myocardial FDG uptake, background-blood pool uptake, and myocardial to background index (M/B) calculated for 
group 1 and group 2
SUVmax 
Mean ± SD 
(range)
Group 1  
(optimal uptake)
Group 2  
(suboptimal and uninterpretable uptake)
p
Myocardial 9.6 ± 4.06 
(1.3–19.7)
3.61 ± 1.53 
(1.4–6.1)
0.0001
Left ventricle 1,57 ± 0.66 
(0.3–3.1)
2.48 ± 0.96 
(1.3–4.1)
0.05
Aorta 1.46 ± 0.62 
(0.18–2.8)
2.32 ± 0.69 
(1.4–3.7)
0.03
M/B index 6.87 ± 3.99 
(2.5–21.2)
1.65 ± 0.78 
(0.34–3.1)
0.0001
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for prolonged time, image repetition may be difficult with regard 
to logistic reasons. Furthermore, the increase in blood pool ac-
tivity may be caused by other reasons, e.g., inadequate patient 
preparation with high free fatty acid and low insulin plasma levels, 
insulin resistance, impaired glucose tolerance, diabetes mellitus, 
or elevated plasma glucose concentrations. There is also a need 
for careful placement of the background ROI because high FDG 
concentration in myocardial muscle surrounding the ventricular ca- 
vity can cause false results due to partial volume defects. To avoid 
technical problems with the assessment of left ventricular blood 
activity due to the high muscle activity, in our study, the background 
activity was calculated and compared for two areas: Inside the left 
ventricle and in the descending aorta. There were no significant 
differences between assessments in both regions.
Importance of preparation methods for FDG PET/CT
The complexity of myocardial metabolism depends on many dif-
ferent factors, including substrate availability, hormones, age, BMI, 
and the patient’s health, which influence the quality and accuracy 
of the study. There are two main protocols for patient preparation 
for FDG PET/CT studies, which are used routinely: scanning after 
overnight fasting used usually in oncological protocols and a glu-
cose load protocol used in FDG myocardial viability studies. Several 
authors have reported varying degrees of non-specific myocardial 
FDG uptake despite low blood sugar levels. De Groot et al. [14] 
found that myocardial FDG uptake had no correlation with the 
fasting blood sugar level, fasting period, or age of the patient. In 
a similar study Kaneta et al. found a negative correlation between 
the blood glucose level and FDG uptake, but the fasting period 
and age of the patient showed no relationship [15]. We found 
no significant correlation between the degree of myocardial FDG 
uptake and the blood glucose level, either at the beginning or at 
the time of FDG injection. There was also no significant difference 
in the time from injection to image acquisition.
SUVmax calculations
Although many well known factors can affect the accuracy of 
SUV measurement, including patient weight, blood glucose level, 
length of uptake period, partial-volume effect, recovery coefficient, 
algorithm of reconstruction used and type of region of interest, 
this assessment of FDG uptake is widely used.
Many publications describing cardiac SUVmax assessment 
applies to the sarcoidosis [16, 17] or assessment of normal myo-
cardial uptake [18] or the comparison of different PET acquisition 
methods [19]. Other studies focus on the clinical factors affecting 
myocardial FDG uptake [20]. Our study concerns the patients with 
coronary artery disease who needs semiquantitative validation 
of the amount of viable myocardium before the final decision of 
the revascularization. In our clinical experience many myocardial 
scans with high background activity are not conclusive and the 
repeat acquisition is essential. 
Rahbar et al. [7] analyzed SUVmax values in a group of 24 
patients with myocardial tumors and found statistically significant 
differences between malignant and benign tumors (2.8 vs. 8.0, re-
spectively). However, semiquantitative assessments of myocardial 
FDG accumulation should be treated with caution, considering the 
non-specific heterogeneous uptake with the wide range of physi-
ological myocardial SUVmax values (even in a fasting state) and 
poorly estimated physiologic SUVmax range of the myocardium 
after a glucose load protocol. 
In conclusion, an M/B index of 2.2 was found to be the cut-off 
value for scans of optimal quality; however, their mean value 
was much higher (6.87). In our opinion, the assessment of the 
M/B index in clinical practice may play an important role, espe-
cially in semiquantitative and quantitative myocardial metabolism 
analyses in polar map (bulls eye) presentations. If the FDG blood 
pool activity is insufficiently cleared from the LV cavity, it is pos-
sible to overestimate the myocardial FDG activity due to partial 
volume defects. The majority of commercially available software 
solutions should be used with caution because they were originally 
developed for single positron emission CT techniques. Although 
they are easily applicable for quantitative and semiquantitative as-
sessment of myocardial tracer accumulation, they may not have 
been validated for PET. Therefore, PET/CT image quality, as well 
as the SUVmax and M/B index, should be assessed before seg-
mental calculations are applied. 
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